Guttman-Yassky E - Search Results

1

Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.

Malik K, Guttman-Yassky E. Malik K, et al. J Investig Dermatol Symp Proc. 2018 Jan;19(1):S62-S64. doi: 10.1016/j.jisp.2017.10.005. J Investig Dermatol Symp Proc. 2018. PMID: 29273110 Free article. Review.

2

Atopic dermatitis.

Guttman-Yassky E. Guttman-Yassky E. Curr Probl Dermatol. 2007;35:154-172. doi: 10.1159/000106422. Curr Probl Dermatol. 2007. PMID: 17641497 Review.

3

Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts.

Guttman-Yassky E, Nograles KE, Krueger JG. Guttman-Yassky E, et al. J Allergy Clin Immunol. 2011 May;127(5):1110-8. doi: 10.1016/j.jaci.2011.01.053. Epub 2011 Mar 8. J Allergy Clin Immunol. 2011. PMID: 21388665 Review.

4

Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.

Guttman-Yassky E, Nograles KE, Krueger JG. Guttman-Yassky E, et al. J Allergy Clin Immunol. 2011 Jun;127(6):1420-32. doi: 10.1016/j.jaci.2011.01.054. Epub 2011 Mar 21. J Allergy Clin Immunol. 2011. PMID: 21419481 Review.

5

New era of biologic therapeutics in atopic dermatitis.

Guttman-Yassky E, Dhingra N, Leung DY. Guttman-Yassky E, et al. Expert Opin Biol Ther. 2013 Apr;13(4):549-61. doi: 10.1517/14712598.2013.758708. Epub 2013 Jan 16. Expert Opin Biol Ther. 2013. PMID: 23323893 Free PMC article. Review.

6

Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.

Suárez-Fariñas M, Dhingra N, Gittler J, Shemer A, Cardinale I, de Guzman Strong C, Krueger JG, Guttman-Yassky E. Suárez-Fariñas M, et al. J Allergy Clin Immunol. 2013 Aug;132(2):361-70. doi: 10.1016/j.jaci.2013.04.046. Epub 2013 Jun 15. J Allergy Clin Immunol. 2013. PMID: 23777851 Free PMC article.

7

Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitis.

Dhingra N, Gulati N, Guttman-Yassky E. Dhingra N, et al. J Invest Dermatol. 2013 Oct;133(10):2311-2314. doi: 10.1038/jid.2013.239. J Invest Dermatol. 2013. PMID: 24030647 Free PMC article.

8

Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.

Czarnowicki T, Krueger JG, Guttman-Yassky E. Czarnowicki T, et al. J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):371-9; quiz 380-1. doi: 10.1016/j.jaip.2014.03.006. Epub 2014 Apr 25. J Allergy Clin Immunol Pract. 2014. PMID: 25017523 Review.

9

A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis.

Dhingra N, Guttman-Yassky E. Dhingra N, et al. J Invest Dermatol. 2014 Aug;134(8):2071-2074. doi: 10.1038/jid.2014.141. J Invest Dermatol. 2014. PMID: 25029321 Free PMC article.

10

Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.

Hamilton JD, Suárez-Fariñas M, Dhingra N, Cardinale I, Li X, Kostic A, Ming JE, Radin AR, Krueger JG, Graham N, Yancopoulos GD, Pirozzi G, Guttman-Yassky E. Hamilton JD, et al. J Allergy Clin Immunol. 2014 Dec;134(6):1293-1300. doi: 10.1016/j.jaci.2014.10.013. J Allergy Clin Immunol. 2014. PMID: 25482871 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters